Concepedia

Publication | Open Access

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

DOIFull Paper Access

445

Citations

13

References

2021

Year

Lisa M. Dunkle, Karen L. Kotloff, Cynthia L. Gay, Germán Áñez, Jeffrey Adelglass, Alejandro Quintín Barrat Hernández, Wayne L. Harper, Daniel M. Duncanson, Monica A. McArthur, Diana F. Florescu,
New England Journal of Medicine

Abstract

NVX-CoV2373 was safe and effective for the prevention of Covid-19. Most breakthrough cases were caused by contemporary variant strains. (Funded by Novavax and others; PREVENT-19 ClinicalTrials.gov number, NCT04611802.).

References

YearCitations

Page 1